Pricing
Navire Pharma
Contact
No bio yet
Pedro J. Beltran
SVP & Head of Biology for Oncology
Eli Wallace
Chief Scientific Officer, Residence for Oncology
6 people, 0 jobs
This person is not in any offices
Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat cancers.
Industries
Headquarters
Employees
Links
Gramener
D&K Engineering
Maxion Wheels
Tremend Software Consulting
View more